Paper36930672
COVID-19 infection, reinfection, and the transition to endemicity.
Cohen C and 1 other. Lancet, 2023. Cited by 27 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. COVID-19 infection, reinfection, and the transition to endemicity. Papers, record 36930672. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36930672
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics3
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Reinfection | Major topic |
| COVID-19 | Major topic |
| Humans |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment on | 36,930,674 | Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. | https://conductscience.org/library/papers/36930674 |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33,308,423 | Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. | Lancet Public Health | 2021 | https://conductscience.org/library/papers/33308423 | PubMed |
| 2 | 35,637,337 | An early warning system for emerging SARS-CoV-2 variants. | Nat Med | 2022 | https://conductscience.org/library/papers/35637337 | PubMed |
| 3 | 35,361,968 | Defining the risk of SARS-CoV-2 variants on immune protection. | Nature | 2022 | https://conductscience.org/library/papers/35361968 | PubMed |
| 4 | 35,298,900 | SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21. | Lancet Infect Dis | 2022 | https://conductscience.org/library/papers/35298900 | PubMed |
| 5 | 36,355,774 | Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. | PLoS Med | 2022 | https://conductscience.org/library/papers/36355774 | PubMed |
| 6 | 36,930,674 | Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis. | Lancet | 2023 | https://conductscience.org/library/papers/36930674 | PubMed |
| 7 | 36,436,752 | Outcomes of laboratory-confirmed SARS-CoV-2 infection during resurgence driven by Omicron lineages BA.4 and BA.5 compared with previous waves in the Western Cape Province, South Africa. | Int J Infect Dis | 2023 | https://conductscience.org/library/papers/36436752 | PubMed |
| 8 | 15,557,003 | Dynamical resonance can account for seasonality of influenza epidemics. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15557003 | PubMed |
| 9 | 36,375,482 | Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study. | Lancet Microbe | 2022 | https://conductscience.org/library/papers/36375482 | PubMed |
| 10 | 35,289,632 | Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa. | Science | 2022 | https://conductscience.org/library/papers/35289632 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,275,303 | Spatio-temporal modelling of COVID-19 infection and associated risk factors in Dakar, Senegal. | PLOS Glob Public Health | 2026 | https://conductscience.org/library/papers/42275303 | PubMed |
| 42,269,558 | Biochemical insights and microRNA profiling via next-generation sequencing in moderate and severe COVID-19 cases. | Clinics (Sao Paulo) | 2026 | https://conductscience.org/library/papers/42269558 | PubMed |
| 42,008,611 | Workflow‑Based Information Management Framework for Multicenter Research Studies: Design and Development. | Online J Public Health Inform | 2026 | https://conductscience.org/library/papers/42008611 | PubMed |
| 41,306,787 | Burden of SARS-CoV-2 infection and severe illness in South Africa (March 2020-August 2022): a synthesis of epidemiological data. | BMJ Public Health | 2025 | https://conductscience.org/library/papers/41306787 | PubMed |
| 41,286,664 | SARS-CoV-2 reinfection in interstitial lung disease patients and its association with clinical deterioration: a two-year prospective cohort study. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41286664 | PubMed |
| 41,258,470 | A public health perspective of SARS-CoV-2 evolution and surveillance strategies in Germany from 2020 to 2023. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/41258470 | PubMed |
| 41,225,355 | COVID-19 re-infection: a large cross-sectional population-based study in the northeast of Iran. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41225355 | PubMed |
| 40,918,512 | Identification of gene signatures and potential pharmaceutical candidates linked to COVID-19-related depression based on gene expression profiles. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40918512 | PubMed |
| 40,882,614 | SARS-CoV-2 Antibody Prevalence Across Unvaccinated Health Care Workers During the COVID-19 Pandemic in Yemen: Cross-Sectional Study. | JMIR Public Health Surveill | 2025 | https://conductscience.org/library/papers/40882614 | PubMed |
| 40,751,140 | Clinical and immunological insights into SARS-CoV-2 reinfection: a propensity score-matched cohort study. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/40751140 | PubMed |
| 40,502,815 | The Clinical and Metabolic Profiles in Menstrual Changes Among Reproductive-Aged Women Post-COVID-19. | MedComm (2020) | 2025 | https://conductscience.org/library/papers/40502815 | PubMed |
| 39,839,844 | Evaluation of the Content Validity of the COVID-19 Symptoms Daily Diary. | Patient Relat Outcome Meas | 2025 | https://conductscience.org/library/papers/39839844 | PubMed |
| 39,760,090 | Longitudinal ozone exposure and SARS-CoV-2 infection in late pregnancy: a retrospective cohort study. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/39760090 | PubMed |
| 39,589,982 | Surface-Enhanced Raman Scattering Combined with Machine Learning for Rapid and Sensitive Detection of Anti-SARS-CoV-2 IgG. | Biosensors (Basel) | 2024 | https://conductscience.org/library/papers/39589982 | PubMed |
| 39,439,168 | Prevalence and Risk Factors of COVID-19 Reinfection in Patients with Rheumatoid Arthritis: A Retrospective Observational Study. | Yonsei Med J | 2024 | https://conductscience.org/library/papers/39439168 | PubMed |
| 39,349,727 | Developing a Coccidioides posadasii and SARS-CoV-2 Co-infection Model in the K18-hACE2 Transgenic Mouse. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/39349727 | PubMed |
| 38,881,657 | Clinical and prognostic implications of hyaluronic acid in patients with COVID-19 reinfection and first infection. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38881657 | PubMed |
| 38,304,972 | Safety and efficiency of COVID-19 vaccine in North Africa. | Hum Vaccin Immunother | 2024 | https://conductscience.org/library/papers/38304972 | PubMed |
| 37,750,684 | Longitudinal kinetics of neutralizing antibodies against circulating SARS-CoV-2 variants and estimated level of group immunity of booster-vaccinated individuals during omicron-dominated COVID-19 outbreaks in the Republic of Korea, 2022. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37750684 | PubMed |
| 37,174,613 | Understanding the Relationship of the Human Bacteriome with COVID-19 Severity and Recovery. | Cells | 2023 | https://conductscience.org/library/papers/37174613 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36930672
GET https://conductscience.org/api/papers/v1/36930672/authors